These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 24323311)
1. The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma. El-Najjar I; Montoto S; McDowell A; Matthews J; Gribben J; Szyszko TA Nucl Med Commun; 2014 Mar; 35(3):311-5. PubMed ID: 24323311 [TBL] [Abstract][Full Text] [Related]
2. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723 [TBL] [Abstract][Full Text] [Related]
3. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
5. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT. Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [ Liang X; Yang C; Su M; Zou L Curr Med Res Opin; 2024 May; 40(5):803-811. PubMed ID: 38626218 [TBL] [Abstract][Full Text] [Related]
11. The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma. Perry C; Lerman H; Joffe E; Sarid N; Amit O; Avivi I; Kesler M; Ben-Ezra J; Even-Sapir E; Herishanu Y Medicine (Baltimore); 2016 Mar; 95(9):e2910. PubMed ID: 26945387 [TBL] [Abstract][Full Text] [Related]
12. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Moulin-Romsee G; Hindié E; Cuenca X; Brice P; Decaudin D; Bénamor M; Brière J; Anitei M; Filmont JE; Sibon D; de Kerviler E; Moretti JL Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1095-105. PubMed ID: 20204358 [TBL] [Abstract][Full Text] [Related]
13. Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Blase PE; Nievelstein RA; de Klerk JM Skeletal Radiol; 2014 Sep; 43(9):1231-6. PubMed ID: 24902511 [TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma. St-Pierre F; Broski SM; LaPlant BR; Maurer MJ; Ristow K; Thanarajasingam G; Macon WR; Habermann TM; Witzig TE Oncologist; 2020 Aug; 25(8):689-695. PubMed ID: 32319706 [TBL] [Abstract][Full Text] [Related]
15. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma. Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235 [TBL] [Abstract][Full Text] [Related]
16. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. Agrawal K; Mittal BR; Bansal D; Varma N; Srinivasan R; Trehan A; Manohar K; Kashyap R; Bhattacharya A; Marwaha RK Ann Nucl Med; 2013 Feb; 27(2):146-51. PubMed ID: 23143537 [TBL] [Abstract][Full Text] [Related]
17. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers. Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Simonitsch-Klupp I; Raderer M; Mayerhoefer ME Acad Radiol; 2018 Apr; 25(4):453-460. PubMed ID: 29199055 [TBL] [Abstract][Full Text] [Related]
18. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874 [TBL] [Abstract][Full Text] [Related]
19. Utility of Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587 [TBL] [Abstract][Full Text] [Related]
20. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]